Agilent Technologies and Applied Spectral Imaging Announce Co-Marketing Agreement for Fluorescence In Situ Hybridization

SANTA CLARA & CARLSBAD, Calif.--(BUSINESS WIRE)--

Agilent Technologies Inc. A and Applied Spectral Imaging (ASI) today announced they have entered into an agreement to jointly market ASI's most advanced GenASIs imaging platforms and Agilent's fluorescence in situ hybridization (FISH) products and solutions, including its Dako Omnis instrument for automated FISH sample processing.

This agreement is expected to bring to pathology labs the components for a fully automated, end-to-end FISH workflow.

"We are excited to work with ASI," said Herman Verrelst, vice president and general manager of Agilent's Genomics Solutions Division and Clinical Applications Division. "Difficulty of fluorescence-based molecular analysis has always been a major pain point for our customers. We anticipate that Agilent's broad portfolio of FISH reagents and instruments, and ASI's industry-leading computer-aided imaging solutions, will address such critical customer needs and enable laboratories to have a standardized, efficient and high-quality FISH workflow."

"ASI is proud to partner with Agilent, a global leader in diagnostics that shares our main objective to make patient care better," said Limor Shiposh, chief executive officer of ASI. "This agreement will position both companies to support customers in all stages of workflows."

About ASI

ASI is a global leader in the development of imaging solutions, supporting fluorescent, brightfield and spectral image-acquisition, for karyotyping, FISH and various pathology tests.

The GenASIs automated imaging platforms for pathology and genetic analysis provide advanced diagnostic aids for pathologists and cytogeneticists, with reproducible and reliable results. GenASIs platforms can be used with any brand of brightfield or fluorescence microscope, and support manual and automatic scanning for a wide range of workflows and applications, to best suit the needs, size and budget of any lab.

ASI serves clinical laboratories, life science companies and research institutions in over 50 countries. Information about ASI is available at www.spectral-imaging.com.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenue of $4.04 billion in fiscal 2015 and employs about 12,000 people worldwide. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news.

EDITORIAL CONTACTS:
Agilent
Victoria Wadsworth-Hansen, +1 408-553-2005
victoria.wadsworth-hansen@agilent.com
or
Applied Spectral Imaging
+1 800-611-3466
sales@spectral-imaging.com

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!